Evidence map›Paper›PMID 35950203›Full record

ArticleClinical hematology international2022

Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma.

Kellen Gil, Saqib Abbasi, Kathan Mehta, Brian McClune, Douglas Sborov, Nausheen Ahmed, Al-Ola Abdallah, Siddhartha Ganguly, Joseph McGuirk, Leyla Shune and 1 more

Abstract read
In one paragraph

Article in Clinical hematology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kellen GilDepartment of Internal Medicine, University of Colorado School of Medicine, Aurora, USA.ORCID 0000-0001-8823-2620
Saqib AbbasiDepartment of Hematological Malignancies and Cellular Therapeutics, Kansas University Medical Center, Kansas City, USA.
Kathan MehtaDepartment of Oncology, Kansas University Medical Center, Kansas City, USA.
Brian McCluneDivision of Hematology and Hematological Malignancies, University of Utah, Salt Lake City, USA.
Douglas SborovDivision of Hematology and Hematological Malignancies, University of Utah, Salt Lake City, USA.
Nausheen AhmedDepartment of Hematological Malignancies and Cellular Therapeutics, Kansas University Medical Center, Kansas City, USA.
Al-Ola AbdallahDepartment of Hematological Malignancies and Cellular Therapeutics, Kansas University Medical Center, Kansas City, USA.
Siddhartha GangulyDepartment of Hematological Malignancies and Cellular Therapeutics, Kansas University Medical Center, Kansas City, USA.
Joseph McGuirkDepartment of Hematological Malignancies and Cellular Therapeutics, Kansas University Medical Center, Kansas City, USA.
Leyla ShuneDepartment of Hematological Malignancies and Cellular Therapeutics, Kansas University Medical Center, Kansas City, USA.
Ghulam Rehman MohyuddinDivision of Hematology and Hematological Malignancies, University of Utah, Salt Lake City, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35950203
PMCPMC9358787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.